DEXCOM, INC. Restructuring Charges
DEXCOM, INC. (DXCM) reported Restructuring Charges of $8.00 million for the 11-month period ending 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-02-13
- DEXCOM, INC. restructuring charges for fiscal 2011 was $0.00.
- DEXCOM, INC. restructuring charges for fiscal 2010 was $0.00.
- DEXCOM, INC. restructuring charges for fiscal 2009 was -$362.00K.
| Period end | Restructuring Charges 1 month | Restructuring Charges 5 month | Restructuring Charges 5 month as first filed | Restructuring Charges 11 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $8.00M 10-K · filed 2020-02-13 | ||||
| 2019-06-30 | $8.00M 10-Q · filed 2019-11-06 | $9.00M 10-Q · filed 2019-07-31 | |||
| 2019-02-28 | $9.00M 10-Q · filed 2019-05-01 | ||||
| 2011-12-31 | $0.00 10-K · filed 2012-02-23 | ||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-23 | ||||
| 2009-12-31 | -$362.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |